CALCRL and coronary artery disorder: By integrating transcriptomic and proteomic data in multitrait colocalization, 13 pleiotropic loci influenced CAD and cancer risk via differential gene or protein expression of neighboring genes, including CALCRL, ANGPTL4, and LAMC1, targets of approved or investigational medications.